Trademark: 97260195
Word
EYLONGIR
Status
Pending
Status Code
731
Status Date
Saturday, January 27, 2024
Serial Number
97260195
Mark Type
4000
Filing Date
Wednesday, February 9, 2022
Published for Opposition
Tuesday, November 1, 2022
Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Owner At Publication
Classifications
5 Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders
Trademark Events
Jan 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2024
Sou Extension 2 Granted
Dec 14, 2023
Sou Extension 2 Filed
Jan 4, 2024
Case Assigned To Intent To Use Paralegal
Dec 14, 2023
Sou Teas Extension Received
May 30, 2023
Notice Of Approval Of Extension Request E-Mailed
May 26, 2023
Sou Extension 1 Granted
May 26, 2023
Sou Extension 1 Filed
May 26, 2023
Sou Teas Extension Received
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 26, 2022
Approved For Pub - Principal Register
Sep 26, 2022
Assigned To Examiner
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 15, 2022
New Application Office Supplied Data Entered
Feb 12, 2022
New Application Entered
VERSA GRIPPS XTEND
97260196
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov